Analysts Downgrades

Cray Inc. (CRAY) Lowered to “Hold” at Needham & Company LLC

Cray Inc. (CRAY) Lowered to “Hold” at Needham & Company LLC

Cray Inc. (NASDAQ:CRAY) was downgraded by equities research analysts at Needham & Company LLC from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday, MarketBeat.com reports. In related news, SVP Ryan W. J. Waite sold 1,406 shares of the firm’s stock in a transaction dated Thursday, February 25th. The […]
Opower Inc (OPWR) Downgraded by Cowen and Company

Opower Inc (OPWR) Downgraded by Cowen and Company

Opower Inc (NASDAQ:OPWR) was downgraded by stock analysts at Cowen and Company from an “outperform” rating to a “market perform” rating in a report issued on Wednesday, The Fly reports. In related news, EVP Jeremy Kirsch sold 83,199 shares of Opower stock in a transaction on Friday, March 11th. The stock was sold at an […]
Your Community Bankshares Inc (YCB) Lowered to “Market Perform” at Hovde Group

Your Community Bankshares Inc (YCB) Lowered to “Market Perform” at Hovde Group

Your Community Bankshares Inc (NASDAQ:YCB) was downgraded by Hovde Group from an “outperform” rating to a “market perform” rating in a note issued to investors on Wednesday, The Fly reports. YCB has been the topic of several other research reports. Keefe, Bruyette & Woods lifted their price objective on Your Community Bankshares from $33.50 to […]
Quintiles Transnational Holdings Inc (Q) Downgraded by Robert W. Baird

Quintiles Transnational Holdings Inc (Q) Downgraded by Robert W. Baird

Quintiles Transnational Holdings Inc (NYSE:Q) was downgraded by research analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a research note issued to investors on Wednesday, StockTargetPrices.com reports. Quintiles Transnational Holdings (NYSE:Q) opened at 67.46 on Wednesday. Quintiles Transnational Holdings has a 12 month low of $55.01 and a 12 […]
Glu Mobile Inc. (GLUU) Stock Rating Lowered by Roth Capital

Glu Mobile Inc. (GLUU) Stock Rating Lowered by Roth Capital

Glu Mobile Inc. (NASDAQ:GLUU) was downgraded by equities research analysts at Roth Capital from a “buy” rating to a “neutral” rating in a research note issued to investors on Wednesday, StockTargetPrices.com reports. They currently have a $2.50 price objective on the stock, down from their prior price objective of $4.15. Roth Capital’s price target suggests […]
EXACT Sciences Co. (EXAS) Downgraded to Neutral at Mizuho

EXACT Sciences Co. (EXAS) Downgraded to Neutral at Mizuho

EXACT Sciences Co. (NASDAQ:EXAS) was downgraded by investment analysts at Mizuho from a “buy” rating to a “neutral” rating in a research note issued on Wednesday, StockTargetPrices.com reports. In other EXACT Sciences news, CEO Kevin T. Conroy purchased 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 1st. The shares […]
TICC Capital Corp. (TICC) Downgraded by Barclays to Underweight

TICC Capital Corp. (TICC) Downgraded by Barclays to Underweight

TICC Capital Corp. (NASDAQ:TICC) was downgraded by Barclays from an “equal weight” rating to an “underweight” rating in a research note issued to investors on Wednesday, StockTargetPrices.com reports. They currently have a $4.00 target price on the investment management company’s stock, down from their previous target price of $5.00. Barclays’ target price points to a […]
Relypsa Inc (RLYP) Downgraded by Mizuho

Relypsa Inc (RLYP) Downgraded by Mizuho

Relypsa Inc (NASDAQ:RLYP) was downgraded by research analysts at Mizuho from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Wednesday, StockTargetPrices.com reports. In other news, Director Thomas J. Schuetz bought 30,000 shares of the company’s stock in a transaction dated Tuesday, March 15th. The stock was […]
Pacira Pharmaceuticals Inc (PCRX) Rating Lowered to Sell at TheStreet

Pacira Pharmaceuticals Inc (PCRX) Rating Lowered to Sell at TheStreet

Pacira Pharmaceuticals Inc (NASDAQ:PCRX) was downgraded by stock analysts at TheStreet from a “hold” rating to a “sell” rating in a research note issued to investors on Monday, Analyst Ratings Network.com reports. Pacira Pharmaceuticals (NASDAQ:PCRX) traded up 2.04% during mid-day trading on Monday, hitting $51.54. 1,394,152 shares of the stock were exchanged. The stock’s 50 […]
Citizens & Northern Co. (CZNC) Downgraded by TheStreet to “Hold”

Citizens & Northern Co. (CZNC) Downgraded by TheStreet to “Hold”

Citizens & Northern Co. (NASDAQ:CZNC) was downgraded by equities researchers at TheStreet from a “buy” rating to a “hold” rating in a report released on Monday, MarketBeat reports. Shares of Citizens & Northern Co. (NASDAQ:CZNC) traded down 1.43% during mid-day trading on Monday, hitting $20.01. 18,398 shares of the stock traded hands. Citizens & Northern […]
Flextronics International Ltd. (FLEX) Rating Lowered to Sell at Zacks Investment Research

Flextronics International Ltd. (FLEX) Rating Lowered to Sell at Zacks Investment Research

Flextronics International Ltd. (NASDAQ:FLEX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, MarketBeat.com reports. According to Zacks, “Flextronic International is a leading provider of advanced electronics manufacturing services to OEMs primarily in the telecommunications and networking, consumer electronics and computer […]
Flextronics International Ltd. (FLEX) Rating Lowered to Sell at Zacks Investment Research

Flextronics International Ltd. (FLEX) Rating Lowered to Sell at Zacks Investment Research

Flextronics International Ltd. (NASDAQ:FLEX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, MarketBeat.com reports. According to Zacks, “Flextronic International is a leading provider of advanced electronics manufacturing services to OEMs primarily in the telecommunications and networking, consumer electronics and computer […]
Zacks Investment Research Lowers FibroGen Inc (FGEN) to Sell

Zacks Investment Research Lowers FibroGen Inc (FGEN) to Sell

FibroGen Inc (NASDAQ:FGEN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday, ARN reports. According to Zacks, “FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and […]
Zacks Investment Research Downgrades Forrester Research, Inc. (FORR) to Sell

Zacks Investment Research Downgrades Forrester Research, Inc. (FORR) to Sell

Forrester Research, Inc. (NASDAQ:FORR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday, AnalystRatings.Net reports. According to Zacks, “Forrester Research, Inc. is a leading independent Internet research firm that conducts research and analysis on the impact of the Internet and emerging technologies on […]
Forestar Group Inc. (FOR) Downgraded by Zacks Investment Research to “Hold”

Forestar Group Inc. (FOR) Downgraded by Zacks Investment Research to “Hold”

Forestar Group Inc. (NYSE:FOR) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Tuesday, MarketBeat reports. According to Zacks, “Forestar Group, Inc. formerly known as Forestar Real Estate Group Inc. operates in two business segments: real estate and natural resources. The real estate […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.